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Conversion of tyrosine phenol-lyase to dicarboxylic amino acid
beta-lyase, an enzyme not found in nature
Abstract
Tyrosine phenol-lyase (TPL), which catalyzes the beta-elimination reaction of L-tyrosine, and aspartate
aminotransferase (AspAT), which catalyzes the reversible transfer of an amino group from dicarboxylic
amino acids to oxo acids, both belong to the alpha-family of vitamin B6-dependent enzymes. To switch
the substrate specificity of TPL from L-tyrosine to dicarboxylic amino acids, two amino acid residues of
AspAT, thought to be important for the recognition of dicarboxylic substrates, were grafted into the
active site of TPL. Homology modeling and molecular dynamics identified Val-283 in TPL to match
Arg-292 in AspAT, which binds the distal carboxylate group of substrates and is conserved among all
known AspATs. Arg-100 in TPL was found to correspond to Thr-109 in AspAT, which interacts with
the phosphate group of the coenzyme. The double mutation R100T/V283R of TPL increased the
beta-elimination activity toward dicarboxylic amino acids at least 10(4)-fold. Dicarboxylic amino acids
(L-aspartate, L-glutamate, and L-2-aminoadipate) were degraded to pyruvate, ammonia, and the
respective monocarboxylic acids, e.g. formate in the case of L-aspartate. The activity toward L-aspartate
(kcat = 0.21 s-1) was two times higher than that toward L-tyrosine. beta-Elimination and transamination
as a minor side reaction (kcat = 0.001 s-1) were the only reactions observed. Thus, TPL R100T/V283R
accepts dicarboxylic amino acids as substrates without significant change in its reaction specificity.
Dicarboxylic amino acid beta-lyase is an enzyme not found in nature.
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Tyrosine phenol-lyase (TPL), which catalyzes the
b-elimination reaction of L-tyrosine, and aspartate ami-
notransferase (AspAT), which catalyzes the reversible
transfer of an amino group from dicarboxylic amino
acids to oxo acids, both belong to the a-family of vitamin
B6-dependent enzymes. To switch the substrate specific-
ity of TPL from L-tyrosine to dicarboxylic amino acids,
two amino acid residues of AspAT, thought to be impor-
tant for the recognition of dicarboxylic substrates, were
grafted into the active site of TPL. Homology modeling
and molecular dynamics identified Val-283 in TPL to
match Arg-292 in AspAT, which binds the distal carbox-
ylate group of substrates and is conserved among all
known AspATs. Arg-100 in TPL was found to correspond
to Thr-109 in AspAT, which interacts with the phosphate
group of the coenzyme. The double mutation R100T/
V283R of TPL increased the b-elimination activity to-
ward dicarboxylic amino acids at least 104-fold. Dicar-
boxylic amino acids (L-aspartate, L-glutamate, and L-2-
aminoadipate) were degraded to pyruvate, ammonia,
and the respective monocarboxylic acids, e.g. formate in
the case of L-aspartate. The activity toward L-aspartate
(kcat 5 0.21 s
21) was two times higher than that toward
L-tyrosine. b-Elimination and transamination as a minor
side reaction (kcat 5 0.001 s
21) were the only reactions
observed. Thus, TPL R100T/V283R accepts dicarboxylic
amino acids as substrates without significant change in
its reaction specificity. Dicarboxylic amino acid b-lyase
is an enzyme not found in nature.
The pyridoxal 59-phosphate-dependent enzymes (B6 en-
zymes) catalyze a wide variety of reactions in the metabolism of
amino acids (1). A comparison of amino acid sequences has
shown that the majority of B6 enzymes belong to the large
a/g-superfamily of homologous B6 enzymes (2, 3). Tyrosine
phenol-lyase (TPL)1 of Citrobacter freundii is a member of the
a-family. It catalyzes the b-elimination of L-tyrosine to produce
phenol, pyruvate, and ammonium (Equation 1).
L-Tyrosine 1 H2Oº phenol 1 pyruvate 1 NH4
1 (Eq. 1)
A number of amino acids with suitable leaving groups on Cb,
such as L-serine and O-acyl-L-serines (4), L-cysteine, S-alkyl-L-
cysteines (4, 5), and 3-chloro-L-alanine, are also substrates for
b-elimination. Moreover, TPL has been found to catalyze mark-
edly slower side reactions, i.e. b-replacement reactions (6, 7),
racemization of alanine (8, 9), as well as transamination reac-
tions of its substrates L-tyrosine, L-serine, and of the competi-
tive inhibitors L-alanine, L-phenylalanine, and L-m-tyrosine
(10).
X-ray crystallographic structure analysis has shown the fold-
ing pattern of the polypeptide chain of tetrameric TPL from C.
freundii to be similar to that of dimeric aspartate aminotrans-
ferase (AspAT) (11), which, like TPL, is a member of the a-fam-
ily of pyridoxal 59-phosphate (PLP)-dependent enzymes. De-
spite their similarity in secondary and tertiary structure, the
two enzymes show only low sequence identity, e.g. 23% between
TPL of C. freundii and AspAT of Escherichia coli. AspAT cat-
alyzes the reversible transamination reaction of the dicarboxy-
lic L-amino acids aspartate and glutamate with the cognate
2-oxo acids 2-oxoglutarate and oxalacetate.
The structures of the active sites of TPL and AspAT are
similar; most of the residues that participate in the binding of
the coenzyme and the a-carboxylate group of the substrate in
AspAT (12) are conserved in the structure of TPL (13). Obvi-
ously, these two homologous enzymes use the same protein
scaffold to catalyze different reactions with different sub-
strates. Thus, alteration of the specificity of a given enzyme by
substitution of a limited number of critical amino acid residues
seems feasible. Alignments of amino acid sequences of homol-
ogous enzymes may be used to identify the residues underlying
the differences in their reaction and substrate specificity. Sub-
stitution of the residues to which the substrate binds has
proven successful in changing the substrate specificity of sev-
eral enzymes without destroying their catalytic apparatus
(14–21).
This paper reports a homology modeling approach that, to-
gether with information obtained from structural and mecha-
nistic studies of AspAT, was used to redesign the substrate
specificity of TPL in favor of dicarboxylic amino acids.
EXPERIMENTAL PROCEDURES
Plasmid Construction and Mutagenesis—Plasmid pTZTPL (22) con-
taining the entire coding sequence of C. freundii tyrosine phenol-lyase
was used as template for in vitro mutagenesis. The tpl gene was am-
plified by the polymerase chain reaction using the following two syn-
thetic oligonucleotides as primers: 59-CGCGCGTCGACATAATTAT-
TATTTAGTGATGATGATGATGATGGATATAGTCAAAGCG-39 and 59-
GCGGAGATCTAACTCACTG-39. The first oligonucleotide hybridizes to
the 59 part of the tpl gene and contains six histidine codons (italics), in
frame, just before the stop codon and a new SalI site (underlined). The
second oligonucleotide hybridizes to the unique BglII site (underlined)
in the tpl gene upstream to the transcriptional start point. The result-
ing 1.9-kilobase pair polymerase chain reaction product was cut with
BglII and SalI and subcloned into the BamHI-SalI sites of the expres-
sion vector pTZ18U (Bio-Rad) to generate pTZTPL-His.
The mutants were prepared by polymerase chain reaction from pTZ-
TPL-His using the QuikChangeTM Site-directed Mutagenesis Kit from
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Stratagene and the following primer pairs: R100Ta, 59-CCTACTCAC-
CAGGGGACCGGCGCAGAAAACCTG-39; R100Tb, 59-CAGGTTTTCT-
GCGCCGGTCCCCTGGTGAGTAGG-39; V283Ra, 59-CTTCGTACACA-
CGGACTAAC-39; and V283Rb, 59-GTTAGTCCGTGTGTACGAAG-39.
The insertion of the histidine codons and the mutations was verified by
cycle sequencing (Sequi Therm Long-Read Cycle Sequencing Kit-LC,
Epicentre Technologies) with fluorescent primers using a DNA
sequencer (LI-COR).
Expression and Purification—E. coli SVS370 cells were used as host
for the pTZTPL-His and the mutant plasmids. The cells, grown as
described previously (22), were thawed and suspended in 5 ml of Buffer
A (50 mM sodium phosphate, 300 mM NaCl, 10 mM imidazole, 1 mM
phenylmethylsulfonyl fluoride, 5 mM 2-mercaptoethanol, 0.1 mM PLP,
pH 8.0) per gram of wet weight. The cells were disrupted by three
passages through a French press. Cell debris was removed by centrif-
ugation at 25,000 3 g at 4 °C for 30 min. The supernatant was passed
through a 0.22-mm filter and directly applied onto a 13 3 1-cm column
containing 2–3 ml of nickel-nitrilotriacetic acid-agarose (Qiagen) equil-
ibrated with Buffer A. The column was washed with Buffer A contain-
ing 20 mM imidazole until A280 of the flow-through solution was below
0.01. The TPL protein was then eluted with a 30-ml gradient from 20 to
250 mM imidazole in Buffer A. The pooled TPL fractions were dialyzed
extensively against 0.1 M potassium phosphate, pH 7.0, containing 0.1
mM PLP, 1 mM EDTA, and 5 mM 2-mercaptoethanol. Purified wild-type
and mutant TPLs were stable at least for 1 year when stored at 270 °C
in the same buffer at a concentration of 2–5 mg/ml. All preparations
were pure as indicated by SDS-polyacrylamide gel electrophoresis (10–
15% PHAST-gel from Amersham Pharmacia Biotech).
Protein Determination—The concentration of purified TPLs was de-
termined photometrically (E278
1% 5 8.37; Ref. 5) assuming a subunit
molecular mass of 52.3 kDa (13) which takes into account the molecular
mass of the His6 tag (0.84 kDa). The PLP content of the enzymes was
determined from the absorption spectrum of the enzyme in 0.1 M NaOH,
assuming e388 5 6600 M
21 cm21 (23).
Absorption Spectra of Tyrosine Phenol-lyase—Prior to recording ab-
sorption spectra, the stock enzyme was incubated with 0.5 mM PLP for
1 h at 30 °C and then separated from excess PLP on a short desalting
column (NAPTM 5, Amersham Pharmacia Biotech) equilibrated with 50
mM potassium phosphate, pH 8.0. Absorption spectra were measured
with a 8453 UV-visible diode-array spectrophotometer from
Hewlett-Packard.
Measurement of b-Elimination Activity—The activity of the TPLs
toward various amino acid substrates was measured using the coupled
assay with lactate dehydrogenase and NADH previously described for
tryptophan indole-lyase (24). The standard assay mixture contained 50
mM potassium phosphate, pH 8.0, 5 mM 2-mercaptoethanol, 50 mM PLP,
0.2 mM NADH, 24 units of lactate dehydrogenase from bovine heart
(Sigma), and varying concentrations of amino acid substrate in a final
volume of 1 ml at 25 °C. The reaction was initiated by the addition of
TPL and followed by the decrease in absorbance at 340 nm. Steady-
state kinetic values of kcat and Km were obtained by fitting the data to
the Michaelis-Menten equation using ORIGIN software (Microcal
Software).
Measurement of Transaminase and Racemase Activity—Mutant
TPLs and wild-type enzyme were incubated in 50 mM potassium phos-
phate, pH 8.0, with different amino acids as substrates. Samples were
withdrawn at different times and immediately deproteinized with 1 M
perchloric acid (25). After derivatization with 1-fluoro-2,4-dinitrophe-
nyl-5-L-alanine amide (26), the reaction samples were loaded onto a
reverse-phase high pressure liquid chromatography column (Aquapore
RP-300; 250 3 4.6-mm). Both pyridoxamine 59-phosphate (PMP), pro-
duced by the single turnover half-reaction of transamination, and the
products of racemization can be separated and detected photometrically
at 340 nm by this sensitive assay (27). Alternatively, the increase in
absorbance at 325 nm was used to follow the production of PMP.
Thin Layer Chromatography—Protein was eliminated from the re-
action mixture prior to chromatography by precipitation with 1 M per-
chloric acid (25). Thin layer chromatography was performed on pre-
coated silica gel plates SIL G-25 from Macherey-Nagel in n-pentyl
formate/chloroform/formic acid (20:70:10, v/v). A slightly alkaline solu-
tion of bromcresol green (0.02% in ethanol) was used to develop
the chromatogram. The acids appeared as yellow spots on a blue
background (28).
Formate Dehydrogenase Assay—Formic acid was determined with
the formate dehydrogenase assay. A kit from Boehringer Mannheim
was used according to the supplier’s protocol. Briefly, mutant TPLs
were incubated at 25 °C in 50 mM potassium phosphate, pH 8.0, with
L-aspartate as substrate. Samples were withdrawn at different times
and immediately deproteinized with perchloric acid. Formate was
quantitated by the increase in absorbance at 340 nm due to NAD1
reduction.
Molecular Modeling and Dynamics Simulations—The crystal struc-
ture of the holoenzyme complex with the substrate analog 3-(4-hydroxy-
phenyl) propionic acid (Brookhaven Protein Data Bank, code 2TPL) was
used as parent structure. The substrate analog was replaced by L-
tyrosine, and the external aldimine form 1 (Scheme 1) was created by
introducing a double bond between C49 and the nitrogen atom of the
substrate. Removal of the Ca-hydrogen, change of the hybridization of
the Ca atom from sp3 to sp2, and subsequent minimization led to the
quinonoid intermediate 2. Molecular dynamics simulations of this in-
termediate were performed using the Discover program (Molecular
Simulations) with the consistent valence force field. The cell multipole
method was used instead of a cut-off for the nonbonded interactions.
The temperature was set to 400 K. All hydrogen atoms and explicit
water molecules were included in the simulations with time steps of 1
fs. At the beginning, the whole system was minimized for 2000 steps.
SCHEME 1. Reaction pathways of enzymic b-elimination and transamination of L-aspartate catalyzed by TPL R100T/V283R. E-PLP
denotes the internal aldimine form of the enzyme.
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The outer shell was then kept fixed, and another 2000 steps of minimi-
zation were applied. This was followed by a molecular dynamics simu-
lation, which was initialized at 400 K for 1000 fs. After this initializa-
tion, the outer shell was again kept fixed. The simulation was continued
for a total time of 20 ps. Every 100 fs the potential energy was analyzed.
Within each picosecond, only the structure with the lowest potential
energy was stored, resulting in a total of 20 low energy structures. All
these 20 structures were then minimized for 2500 steps. The resulting
minimized structures were found to be generally quite similar, and one
of these corresponding to the average structure was chosen as starting
point for all further simulations. The modeled structure of the wild-type
enzyme with L-aspartate as substrate was obtained by replacement of
L-tyrosine and applying the same minimization-dynamics procedure as
for the wild-type structure with L-tyrosine as substrate. To model the
double mutant enzyme, we replaced Arg-100 by a threonine and Val-
283 by an arginine residue and applied again the minimization-dynam-
ics procedure.
RESULTS
Design Strategy—In order to change the substrate specificity
of TPL in favor of dicarboxylic amino acids, we compared TPL
with AspAT using homology modeling and molecular dynamic
simulations. The specificity of AspAT for dicarboxylic amino
acids and oxo acids seems to be based primarily on the salt
bridge-hydrogen bond interaction of the side chain of Arg-292
(of the adjacent subunit) with the distal carboxylate group of
these substrates (12). In agreement with this notion, Arg-292 is
conserved among all AspATs (29). Since the sequence identity
between AspAT and TPL is too low (23%) to allow the use of
standard alignment algorithms, comparison of their three-di-
mensional structures (13, 30) by superposition (Fig. 1) and with
the program DALI (Fig. 2) was used to identify in TPL the
residue corresponding to Arg-292 in AspAT. Val-283 in TPL
seems to occupy the same position as Arg-292 in AspAT. An-
other significant difference in the active sites of these two
enzymes is the replacement of a residue interacting with the
phosphate group of the coenzyme. Arg-100 in TPL apparently
corresponds to Thr-109 in AspAT which is also conserved
among all AspATs (Figs. 1 and 2; Ref. 29).
Molecular modeling showed that the quinonoid adduct of
L-aspartate and PLP can be sterically accommodated in the
active site of wild-type TPL (Fig. 3). However, the orientation of
the leaving group of the substrate relative to the planar coen-
zyme-substrate adduct did not appear to be optimum for a
b-elimination reaction. Positively charged Arg-100 in the hy-
drophobic active site of TPL interacted with the distal carbox-
ylate group of dicarboxylic substrates and thus perturbed the
required orthogonal orientation of the plane defined by Ca, Cb,
and Cg of the amino acid substrate relative to the plane defined
by the p system of the coenzyme-substrate adduct including Cb
(Scheme 1; Ref. 33). This notion agrees with previous studies by
Faleev et al. (34) who have reported that aspartic and glutamic
acid are not substrates but, in view of the low hydrophobicity of
their side chains, anomalously strong inhibitors of TPL (Ki 5
3.5 and 5.0 mM, respectively). We concluded that the introduc-
tion of an arginine residue into position 283 of TPL together
with the substitution of Arg-100 with an uncharged residue, i.e.
the double mutation R100T/V283R, might mimic the binding
site for dicarboxylic substrates of AspAT and thus result in a
corresponding alteration in the substrate specificity of TPL.
Expression of Wild-type TPL and Mutant TPLs—The C-ter-
minal His6 tag did not interfere with the b-elimination activity
of the enzyme (Table I). The His-tagged TPL R100T/V283R
enzyme and the single mutant TPL R100T were purified and
used for analysis. The single mutant V283R enzyme, however,
could not be expressed as soluble protein. The PLP content of
FIG. 2. Sequence alignment of C. freundii TPL and E. coli
AspAT with the program DALI (Ref. 31, 32; accessible through
the World Wide Web at the following on-line address: http://
www2.ebi.ac.uk/dali/). Identical residues are indicated in bold. Res-
idues that belong to a-helices, b-strands, and b-turns are marked by the
letters h, s, and t, respectively. The amino acid residues in TPL corre-
sponding to Thr-109 and Arg-292 in AspAT are marked with an
asterisk.
FIG. 1. Superposition of the active-site structures of C. freundii TPL (thick lines) and E. coli AspAT (thin lines). The structures
correspond to the quinonoid intermediates with L-tyrosine and L-aspartate, respectively, as obtained by molecular modeling and dynamics
simulations (for details, see “Experimental Procedures”). The Ca atoms of Lys-257, Arg-217, Arg-404, and Val-283 of TPL were superimposed with
the Ca atoms of the corresponding Lys-258, Tyr-225, Arg-386, and Arg-292, respectively, in AspAT. The amino acid residues in TPL corresponding
to Arg-292 and Thr-109 in AspAT are marked with an asterisk.
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the mutant proteins was found to be 1 mol/mol of subunit, as
has been shown previously for wild-type TPL (36). The UV-
visible spectrum of the PLP form of the mutant enzymes is
almost identical to that of the wild-type enzyme. Apparently,
the topochemistry of the PLP-binding site is not significantly
altered by the mutations.
Wild-type TPL in the presence of L-tyrosine exhibits a visible
absorbance peak at about 500 nm attributable to the quinonoid
coenzyme-substrate adduct 2 (Scheme 1; Ref. 8). Some other
amino acids such as L- and D-alanine, L-phenylalanine, L-aspar-
tic acid, L-methionine, and L-homoserine, which are not sub-
strates for b-elimination, form stable quinonoid intermediates
with wild-type TPL (34). TPL R100T also produced stable qui-
nonoid intermediates upon addition of these amino acids. How-
ever, with TPL R100T/V283R no detectable quinonoid adduct
was observed in the presence of any amino acid including
L-tyrosine.
Changes in Substrate Specificity—TPL R100T/V283R and
TPL R100T were tested for b-elimination activity toward L-
tyrosine and dicarboxylic amino acids of various lengths (Table
I). The kcat value of TPL R100T/V283R toward L-tyrosine was
decreased 30-fold as compared with wild-type TPL without
significant change in the Km value. When TPL R100T/V283R
was tested for activity toward dicarboxylic amino acids using
the coupled assay with lactate dehydrogenase and NADH,
pyruvate was detected in the reaction mixtures. Thin layer
chromatographic analyses confirmed the production of pyru-
vate. A yellow spot, the Rf value of which was the same as that
of authentic pyruvate, was detected on the plate as the unique
and invariable oxo acid product of the enzymic reactions with
all dicarboxylic substrates. No 2-oxobutyric acid, which possi-
bly might have been produced by a g-elimination reaction of
L-glutamate, was detected.
The expected products of the b-elimination reaction of the
dicarboxylic substrates L-aspartate, L-glutamate, and L-2-ami-
noadipate are pyruvate, ammonia, and the monocarboxylic ac-
ids formate, acetate, and propionate, respectively. In the case of
L-aspartate, formate was identified and determined using the
coupled assay with formate dehydrogenase and NAD1.
Equimolar amounts of pyruvate and formate were detected
(Table II). Thus, TPL R100T/V283R catalyzes, in contrast to
the wild-type enzyme, the b-elimination reaction of dicarboxy-
lic substrates at least as efficiently or, in the case of L-aspar-
tate, even two times faster than that of L-tyrosine (kcat 5 0.21
s21; Table I). The Km value of TPL R100T/V283R for the b-elim-
ination reaction with L-glutamate was significantly lower than
the Km values with L-aspartate and L-2-aminoadipate. It seems
that L-glutamate has the optimum size for binding among these
dicarboxylic substrates. TPL R100T also catalyzed the b-elim-
ination reaction of the dicarboxylic amino acids L-aspartate,
L-glutamate, and L-2-aminoadipate; however, the reaction was
up to six times slower than that with the double mutant en-
zyme. The Km values were also higher (up to 3 times, in the
case of L-glutamate) as compared with the double mutant en-
zyme. Furthermore, the TPL R100T-catalyzed b-elimination
reaction of L-tyrosine was five times faster than the TPL
R100T/V283R-catalyzed reaction.
We also examined the reaction of TPL R100T/V283R and
TPL R100T with 3-chloro-L-alanine, L-serine, S-methyl-L-cys-
teine, and S-(o-nitrophenyl)-L-cysteine which are good sub-
strates for b-elimination by wild-type TPL (4, 5). The activity
toward 3-chloro-L-alanine was only slightly lower than that of
the wild-type enzyme (Table I). However, no measurable activ-
ity was observed with the other substrates. L-Cysteine sulfi-
nate, which can be considered an analog of L-aspartate, was
inert as substrate with both mutant TPL enzymes.
Changes in Reaction Specificity—TPL R100T/V283R was
also tested for newly generated catalytic activities with a sen-
FIG. 3. Superposition of the active-
site structure of TPL with L-tyrosine
(thick lines) and the modeled struc-
ture with L-aspartate as substrate
(thin lines). The quinonoid intermedi-
ates are shown (for details, see “Experi-
mental Procedures”).
TABLE I
Kinetic parameters for b-elimination reaction of tyrosine phenol-lyase wild-type, R100T, and R100T/V283R mutants
Values were determined in 50 mM potassium phosphate, pH 8.0, at 25 °C. Pyruvate production followed by the coupled assay with lactate
dehydrogenase and NADH. In control reactions with 50 mM PLP but without enzyme, no activity was detected in the case of any substrate. All
enzymes carry a C-terminal His6 tag. The activity of the tagged wild-type enzyme toward L-tyrosine corresponds closely to that of the untagged
wild-type enzyme (35).
Substratea
Wild-type enzyme R100T R100T/V283R
kcat Km kcat/Km kcat Km kcat/Km kcat Km kcat/Km
s21 mM M21 s21 s21 mM M21 s21 s21 mM M21 s21
L-Tyrosine 3.7 0.2 1.85 3 104 0.54b 8.3b 65.1b 0.11 0.32 343.8
L-Aspartate Activity below detection 0.035 56 0.63 0.21 54 3.9
L-Glutamate Activity below detection 0.08 15 5.4 0.10 5.3 18.9
L-2-Aminoadipate Activity below detection 0.095c —c — 0.19c —c —
3-Chloro-L-alanine 3.0d 1.7d 1.8 3 103 1.13 19 59 1.13 46 25
a The concentration ranges of the tested amino acids were as follows: 10–200 mM for dicarboxylic amino acids; 0.2–2 mM for L-tyrosine.
b Owing to the low solubility of tyrosine (up to 2 mM), these values are less certain than those of the TPL R100T/V283R.
c Saturation was not apparent within the concentration range tested. Values measured at a substrate concentration of 120 mM.
d From Ref. 43.
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sitive assay that monitors both the consumption of the amino
acid substrate and the formation of new products (Table III).
TPL R100T/V283R in its pyridoxal form underwent the
transamination half-reaction with L-aspartate and L-glutamate
10 times faster than the wild-type enzyme. It also transami-
nated L-serine and L-alanine two times faster than the wild-
type enzyme. The racemization of L-alanine catalyzed by TPL
R100T/V283R is four times slower than that catalyzed by the
wild-type enzyme.
DISCUSSION
X-ray crystallographic analysis has identified Arg-292 as the
key residue in determining the specificity of AspAT for dicar-
boxylic substrates (12) through direct salt bridge-hydrogen
bond interactions with the b- or g-carboxylate groups of the
substrate. Indeed, replacement of Arg-292 with an aspartate
residue has converted E. coli AspAT from an anionic to a very
slow cationic amino acid transaminase (37). Similarly, substi-
tution of Arg-292 with valine or leucine has been found to
switch the specificity in favor of aromatic amino acids (38).
Recently, the importance of the guanidinium group of arginine
has also been pointed out by the marked decrease in both the
affinity and the catalytic activity toward dicarboxylic sub-
strates upon replacement of Arg-292 with lysine (39).
Here, in an attempt to change the substrate specificity of
TPL from L-tyrosine to dicarboxylic substrates, we introduced
an arginine residue in TPL in the same position that, as indi-
cated by homology modeling, is occupied by Arg-292 in AspAT.
Measurements of enzymic activities demonstrated indeed the
conversion of TPL, a tyrosine b-lyase, to a dicarboxylic amino
acid b-lyase. TPL R100T/V283R catalyzes the b-elimination
reaction of L-aspartate at a 2-fold higher rate than that of
L-tyrosine, the rate of b-elimination of L-aspartate being only 1
order of magnitude slower than that of b-elimination of L-
tyrosine by the wild-type enzyme.
The dicarboxylic amino acids L-aspartate, L-glutamate, and
L-2-aminoadipate are converted to pyruvate, ammonia, and the
respective monocarboxylic acids, e.g. with L-aspartate as sub-
strate, production of formate was observed. The pathway of
formate production from L-aspartate by b-elimination corre-
sponds to that followed by the wild-type enzyme with its nat-
ural substrate L-tyrosine (Scheme 1). Upon formation of the
quinonoid intermediate 2, the coenzyme donates electrons to
the substrate resulting in the cleavage of the bond between Cb
and the nucleophilic leaving group thus producing the amino-
acrylate coenzyme-substrate adduct 3. The cleavage of the al-
iphatic C–C bond very likely is facilitated by an active-site
group which protonates the carbanion of the leaving carboxylic
acid in a concerted fashion. Transimination of the aminoacry-
late intermediate leads to the production of ammonium pyru-
vate 4, restoring the internal aldimine. The fact that no L-
alanine was found in the reaction mixture together with the
production of equimolar amounts of pyruvate and formate dem-
onstrates that no b-decarboxylation occurred. Thus, b-elimina-
tion and slow transamination of L-aspartate (Table III) are the
only reactions taking place. Analogous results have been ob-
tained with L-glutamate and L-2-aminoadipate as substrates. It
has to be noted that the known PLP-dependent carbon-carbon
lyases acting on dicarboxylic amino acids are decarboxylases,
e.g. glutamate decarboxylase (40) and aspartate b-decarboxyl-
ase (41, 42), that produce CO2 and the cognate monocarboxylic
amino acid. The reaction observed here reflects a newly gener-
ated catalytic activity for PLP-dependent enzymes toward di-
carboxylic amino acids. TPL R100T/V283R and TPL R100T are
the first B6 enzymes that catalyze the b-elimination reaction of
these substrates.
The importance of the introduction of an arginine residue at
position 283 for the recognition of dicarboxylic substrates is
evident from a comparison of TPL R100T/V283R with TPL
R100T. The single mutant TPL also catalyzes the b-elimination
reaction of dicarboxylic substrates; however, the double mutant
TPL R100T/V283R reacts faster with L-aspartate, and its Km
value for L-glutamate is lower (Table I). Moreover, the data
agree with the hypothesis that Arg-100 is the positively
charged group in the active site of TPL that interacts with the
distal carboxylate group of L-aspartate or L-glutamate making
them potential inhibitors but not substrates of wild-type TPL.
This mode of inhibition of TPL by dicarboxylic acids has been
proposed previously by Faleev et al. (34). Replacement of Arg-
100 with threonine renders dicarboxylic substrates more flex-
ible in the active site. The additional introduction of Arg-283
might stabilize the side chain carboxylate group in a more
favorable position for reaction due to salt bridge-hydrogen bond
interactions similar to those in AspAT (Fig. 4).
Recent studies (43) have demonstrated that Arg-381 in TPL
is required for the recognition of L-tyrosine as substrate. We
found that not only the R381I enzyme but also the triple mu-
tant TPL R100T/V283R/R381I has no measurable activity to-
ward both L-tyrosine and dicarboxylic substrates (data not
shown).
Apparently, dicarboxylic substrates adopt in the active site of
TPL R100T/V283R a similar configuration as L-tyrosine in
wild-type TPL and interact in a similar way with the critical
residues of TPL that control reaction specificity. Even though
the overall catalytic activity of TPL R100T/V283R toward L-
tyrosine is decreased, its Km value for this substrate is almost
unchanged (Table I) suggesting that the side chain of Arg-283
contributes to the binding of the aromatic ring of L-tyrosine.
Such interactions have been reported to apply in E. coli aro-
matic amino acid aminotransferase (44). How does the side
chain of Arg-283 contribute to the recognition of L-tyrosine?
TABLE II
Stoichiometry of the b-elimination reaction of tyrosine phenol-lyase
R100T/V283R with L-aspartate
The reaction mixture contained 1 mM enzyme, 100 mM L-aspartate
and 100 mM PLP in 50 mM potassium phosphate (pH 8.0). At the
indicated times, samples were withdrawn from the incubation mixture
and analyzed, as described under “Experimental Procedures.”
Time of reaction
Products
Pyruvatea Formate
min mM
5 44.1 43.8
10 88.2 87.7
a Pyruvate was measured using the coupled assay with lactate dehy-
drogenase and NADH.
TABLE III
Kinetic parameters for side reactions of TPL wild-type
and TPL R100T/V283R
The activities of the enzymes were determined in 50 mM potassium
phosphate, pH 8.0, at 30 °C for transamination and 25 °C for racemi-
zation, as described under “Experimental Procedures.”
Substrate Activities
k9cat
Wild-type R100T/V283R
s21
L-Aspartate Transamination 1.1 3 1024a 1.1 3 1023a
L-Glutamate Transamination 1.3 3 1024a 1.5 3 1023a
L-Serine Transamination 1.0 3 1023b 1.8 3 1023a
L-Alanine Transamination 1.5 3 1023b 2.1 3 1023a
Racemization 0.03c 8 3 1023a
a Measured at a single substrate concentration of 250 mM for L-
aspartate, L-glutamate, L-serine, and of 100 mM for L-alanine.
b From Ref. 10.
c From Ref. 9.
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The model of the “arginine switching” mechanism (45) assumes
that the side chain of arginine moves out of the active site,
when aromatic monocarboxylic substrates are bound. This
model has been verified by x-ray crystallographic analysis of
aspartate aminotransferase that has been engineered into a
tyrosine aminotransferase (19, 46). Another model assumes
that the guanidinium group of arginine directly links up with
the aromatic ring of the bound substrates. This interaction may
be energetically favorable (47).
The rate of the transamination half-reaction of dicarboxylic
substrates is increased ten times by the two conjoint muta-
tions. The values of kcat for the transamination of all the sub-
strates studied here are in the order of 1023 s21. Apparently,
the transamination reactions of these substrates depend on a
rate-limiting step that follows the formation of the quinonoid
intermediate 2. The kcat values of TPL R100T/V283R for
transamination by and large coincide with those of the wild-
type enzyme (Table III), indicating again that different active-
site residues are important for the catalysis of b-elimination
and transamination reactions.
In conclusion, the newly generated substrate specificity of
TPL R100T/V283R agrees with previous studies in which the
substrate specificity of B6 enzymes was changed without alter-
ing the reaction specificity by replacement of some critical
active-site residues. The results are thus also consonant with
evolutionary studies indicating that the B6 enzymes originated
from regio-specific catalysts, which first specialized for reaction
specificity and then for substrate specificity (2). The results of
previous attempts to change the substrate specificity of aspar-
tate aminotransferase by both site-directed mutagenesis (19)
and forced molecular evolution (48) suggest that further im-
provement of the engineered dicarboxylic amino acid b-lyase,
i.e. enhancement of its substrate binding affinity and catalytic
efficacy, would require substitutions of numerous amino acid
residues that do not participate in the active site.
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FIG. 4. Superposition of the mod-
eled active-site structure of TPL
R100T/V283R (thick lines) and AspAT
(thin lines). The quinonoid intermedi-
ates with L-aspartate are shown (for de-
tails, see “Experimental Procedures”).
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